Acyclovir
Acyclovir suspension, Avaclyr, Zovirax
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
NADAC/unit
$0.0767
No Shortage
Tier 1: 188.4%
PA Req: 115.5%
34 Manufacturers
56 ANDAs
vs. brand Acyclovir suspension: Generic saves up to 99% per unit
Market Intelligence
2023-01-11 Class II Recall: Eugia US LLC
Generic Manufacturers
ACTAVIS MID ATLANTIC LLCALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS LLCAPOTEX INCAUROBINDO PHARMA LTDAUROBINDO PHARMA USA INCBAUSCH HEALTH US LLCCADILA HEALTHCARE LTDCADILA PHARMACEUTICALS LTDCARLSBAD TECHNOLOGY INCCHARTWELL RX SCIENCES LLCEUGIA PHARMA SPECIALITIES LTDFOUGERA PHARMACEUTICALS INCFRESENIUS KABI USA LLCGLENMARK SPECIALTY SAHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCHETERO LABS LTD UNIT IIIHETERO LABS LTD UNIT VMACLEODS PHARMACEUTICALS LTDMSN LABORATORIES PRIVATE LTDNOVITIUM PHARMA LLCPADAGIS ISRAEL PHARMACEUTICALS LTDPHARMOBEDIENT CONSULTING LLCREGCON HOLDINGS LLCRUBICON RESEARCH LTDSLATE RUN PHARMACEUTICALS LLCSQUARE PHARMACEUTICALS LTDSUN PHARMA CANADA INCTEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDXIROMED PHARMA ESPANA SLYILING PHARMACEUTICAL LTDZYDUS LIFESCIENCES LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.